Distortion product otoacoustic emissions in infant, pregnant and non-pregnant adult rabbits: Comparison for different stimulus levels

Journal of International Advanced Otology

Volumn 7, Issue 1, 2011, Pages 102-110

  Muluk, Nuray Bayar ^a   Budak, Gurer G ^b   Budak, Bilgehan ^c   Apan, Alpaslan ^a   Ozturk, Goknur Guler ^b   Seyhan, Nesrin ^b  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79954481925     PISSN: 13087649     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Duifhuis H. Distortion product otoacoustic emissions: a time domain analysis. ORL J Otorhinolaryngol Relat Spec. 2006;68:340-346. Epub 2006 Oct 26.
2. Knight RD, Kemp DT. Indications of different distortion product otoacoustic emission mechanism from a detailed F1, F2 area study. J. Acoust. Soc. Am. 2000; 107: 457-473.
3. Knight RD, Kemp DT. Wave and place fixed maps of the human ear. J. Acoust. Soc. Am. 2001; 109: 1513-1525.
4. Knight RD, Kemp DT. Relationship between DPOAE and TEOAE amplitude and phase characteristics, J. Acoust. Soc. Am. 1999; 106: 1420-1435.
5. Zweig G, Shera CA. The origin on the periodicity in the spectrum of evoked otoacoustic emissions, J. Acoust. Soc. Am. 1995; 98: 2018-2047.
6. Parazzini M, Bell S, Thuroczy G, Molnar F, Tognola G, Lutman ME, et al. Influence on the mechanisms of generation of distortion product otoacoustic emissions of mobile phone exposure. Hear Res. 2005 Oct; 208:68-78. Epub 2005 Jul 27.
7. Shera CA, Guinan JJ. Evoked otoacoustic emissions arise by two fundamentally different mechamisms: A taxonomy for mammalian OAEs. J. Acoust. Soc. Am. 1999; 105: 782-798.
8. 52nd WMA General Assembly.World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2000; 284: 3043-3049.
9. Smith JL, Sterns AR, Prieve BA, Woods CI. Effects of anesthesia on DPOAE level and phase in rats. Hear Res. 2008 Jan; 235: 47-59. Epub 2007 Oct 6.
10. Otodynamics Ltd, EZ Screen 2 User Manual, Issue December 2004.
11. Hall WJ. Handbook of otoacoustic emissions. Singular Publishing Group, San Diego, 2000, pp 55-88.
12. Muluk NB, Boke B, Apan A, Koc MC. Efficacy of topotecan treatment on an experimental model of transient-evoked otoacoustic emissions. Int J Pediatr Otorhinolaryngol 2001; 61:135-142.
13. Arikan OK, Muluk NB, Budak B, Apan A, Budak G, Koc C. Effects of ropivacaine on transient-evoked otoacoustic emissions: a rabbit model. Eur Arch Otorhinolaryngol. 2006 May; 263: 421-425. Epub 2006 Jan 12.
14. Wagner W, Frey K, Heppelmann G, Plontke SK, Zenner HP. Speech-in-noise intelligibility does not correlate with efferent olivocochlear reflex in humans with normal hearing. Acta Otolaryngol. 2008 Jan;128:53-60.
15. Shaffer LA, Withnell RH, Dhar S, Lilly DJ, Goodman SS, Harmon KM. Sources and mechanisms of DPOAE generation: implications for the prediction of auditory sensitivity. Ear Hear. 2003 Oct; 24: 367-379.
16. Martin GK, Probst R, Lonsbury-Martin BL. "Otoacoustic emissions in human ears: Normative findings". Ear and Hearing 1990; 11: 106-120.
17. Grisanti G, Parlapiano C, Tamburello CC, Tint G, Zaniforlin L. Cellular phones effects on acoustic emissions. 1998 IEEE MTT-S Digest, 771-774. http://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arnumber=705104&isnumber=15192 (Received online on October, 6th, 2009).
18. Chen J, Nathans J. Estrogen-related receptor beta/NR3B2 controls epithelial cell fate and endolymph production by the stria vascularis. Dev Cell. 2007; 13: 325-337.
19. Creasy RK, Resnik R. Maternal-Fetal Medicine, 4th Edition, Philadelphia: W.B. Saunders Company, 1999; pp 1015-1037.
20. Meltser I, Tahera Y, Simpson E, et al. Estrogen receptor beta protects against acoustic trauma in mice. J Clin Invest. 2008; 118: 1563-1570.
21. Sasaki A, Liotta AS, Luckey MM, Margioris AN, Suda T, Krieger DT. Immunoreactive corticotropin-releasing factor is present in human maternal plasma during the third trimester of pregnancy. J Clin Endocrinol Metab. 1984; 59: 812-814.
22. Rees LH, Burke CW, Chard T, Evans SW, Letchworth AT. Possible placental origin of ACTH in normal human pregnancy. Nature. 1975; 254 (5501): 620-622.
23. Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope. 2007;117: 3-15.
24. Rarey KE, Luttge WG. Presence of type I and type II/IB receptors for adrenocorticosteroid hormones in the inner ear. Hear Res 1989; 41: 217-221.
25. Stockroos RJ, Albers FW, Schirm J. The etiology of idiopathic sudden sensorineural hearing loss. Experimental herpes simplex virus infection of the inner ear. Am J Otol 1998; 19: 447-452.
26. Nagura M, Iwasaki S, Wu R, et al. Effects of corticosteroid, contrast medium and ATP on focal microcirculatory disorders of the cochlea. Eur J Pharmacol 1999; 366: 47-53.
27. Tabuchi K, Oikawa K, Uemaetomari I, Tsuji S, Wada T, Hara A. Glucocorticoids and dehydroepiandrosterone sulfate ameliorate ischemia-induced injury of the cochlea. Hear Res 2003; 180: 51-56.
28. Lamm K, Arnold W. The effect of prednisolone and non-steroidal anti-inflammatory agents on the normal and noise-damaged guinea pig inner ear. Hear Res 1998;115:149-161.
29. Yao X, Buhi WC, Alvarez IM, Curtis LM, Rarey KE. De novo synthesis of glucocorticoid hormone regulated inner ear proteins in rats. Hear Res 1995; 86: 183-188.
30. Lin DW, Trune DR. Breakdown of stria vascularis blood-labyrinth barrier in C3H/lpr autoimmune disease mice. Otolaryngol Head Neck Surg 1997; 117: 1-8.
31. Trune DR, Wobig RJ, Kempton JB, Hefeneider SH. Steroid treatment improves cochlear function in the MRL.MpJ-Fas(lpr) autoimmune mouse. Hear Res 1999; 137: 160-166.
32. Kalluri R, Shera CA. Distortion-product source unmixing: A test of the two-mechanism model for DPOAE generation. J. Acoust. Soc. Am. 2001; 92: 622-637.